Surrogate tissue telomere length and cancer risk: Shorter or Longer?

Cancer Letters

Volumn 319, Issue 2, 2012, Pages 130-135

  Hou, Lifang ^a   Zhang, Xiao ^a   Gawron, Andrew J ^a   Liu, Jie ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cancer risk; Surrogate tissue DNA; Telomere length

Indexed keywords

BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GENE; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG CANCER; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; SHORT SURVEY; SKIN CANCER; STOMACH CANCER; SURROGATE TISSUE TELOMERE LENGTH; TELOMERASE GENE; TELOMERE; TELOMERE SHORTENING;

EID: 84862812237     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.01.028     Document Type: Review

References (85)

1. Hug N., Lingner J. Telomere length homeostasis. Chromosoma 2006, 115:413-425.
2. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., Aviv A., Spector T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
3. Wu X., Amos C.I., Zhu Y., Zhao H., Grossman B.H., Shay J.W., Luo S., Hong W.K., Spitz M.R. Telomere dysfunction: a potential cancer predisposition factor. J. Natl. Cancer Inst. 2003, 95:1211-1218.
4. Schonland S.O., Lopez C., Widmann T., Zimmer J., Bryl E., Goronzy J.J., Weyand C.M. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc. Natl. Acad. Sci. USA 2003, 100:13471-13476.
5. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27:339-344.
6. Jennings B.J., Ozanne S.E., Hales C.N. Nutrition, oxidative damage, telomere shortening, and cellular senescence. individual or connected agents of aging?. Mol. Genet. Metab. 2000, 71:32-42.
7. L. Hou, A.J. Gawron, Telomere length and cancer risk: cause or consequence, long or short? in: American Association for Cancer Research (AACR) Education Book, 2010.
8. Sampedro Camarena F., Cano Serral G., Sampedro Santalo F. Telomerase and telomere dynamics in ageing and cancer: current status and future directions. Clin. Transl. Oncol. 2007, 9:145-154.
9. Hodes R.J., Hathcock K.S., Weng N.P. Telomeres in T and B cells. Nat. Rev. Immunol. 2002, 2:699-706.
10. Ornish D., Lin J., Daubenmier J., Weidner G., Epel E., Kemp C., Magbanua M.J., Marlin R., Yglecias L., Carroll P.R., Blackburn E.H. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008, 9:1048-1057.
11. Teixeira M.T., Arneric M., Sperisen P., Lingner J. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 2004, 117:323-335.
12. Smogorzewska A., de Lange T. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 2004, 73:177-208.
13. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
14. Vulliamy T., Marrone A., Dokal I., Mason P.J. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 2002, 359:2168-2170.
15. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
16. Bisoffi M., Heaphy C.M., Griffith J.K. Telomeres: prognostic markers for solid tumors. Int. J. Cancer 2006, 119:2255-2260.
17. Svenson U., Roos G. Telomere length as a biological marker in malignancy. Biochim. Biophys. Acta 2009, 1792:317-323.
18. Wentzensen I.M., Mirabello L., Pfeiffer R.M., Savage S.A. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1238-1250.
19. Ma H., Zhou Z., Wei S., Liu Z., Pooley K.A., Dunning A.M., Svenson U., Roos G., Hosgood H.D., Shen M., Wei Q. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One 2011, 6:e20466.
20. Jang J.S., Choi Y.Y., Lee W.K., Choi J.E., Cha S.I., Kim Y.J., Kim C.H., Kam S., Jung T.H., Park J.Y. Telomere length and the risk of lung cancer. Cancer Sci. 2008, 99:1385-1389.
21. Hosgood H.D., Cawthon R., He X., Chanock S., Lan Q. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung cancer 2009, 66:157-161.
22. Shao L., Wood C.G., Zhang D., Tannir N.M., Matin S., Dinney C.P., Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J. Urol 2007, 178:1492-1496.
23. Broberg K., Bjork J., Paulsson K., Hoglund M., Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26:1263-1271.
24. McGrath M., Wong J.Y., Michaud D., Hunter D.J., De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Biomarkers Prev. 2007, 16:815-819.
25. Mirabello L., Garcia-Closas M., Cawthon R., Lissowska J., Brinton L.A., Peplonska B., Sherman M.E., Savage S.A. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2010, 21:77-82.
26. Pooley K.A., Sandhu M.S., Tyrer J., Shah M., Driver K.E., Luben R.N., Bingham S.A., Ponder B.A., Pharoah P.D., Khaw K.T., Easton D.F., Dunning A.M. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010, 70:3170-3176.
27. Shen J., Gammon M.D., Terry M.B., Wang Q., Bradshaw P., Teitelbaum S.L., Neugut A.I., Santella R.M. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int. J. Cancer 2009, 124:1637-1643.
28. Shen J., Terry M.B., Gurvich I., Liao Y., Senie R.T., Santella R.M. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 2007, 67:5538-5544.
29. Hou L., Savage S.A., Blaser M.J., Perez-Perez G., Hoxha M., Dioni L., Pegoraro V., Dong L.M., Zatonski W., Lissowska J., Chow W.H., Baccarelli A. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol. Biomarkers Prev. 2009, 18:3103-3109.
30. Liu X., Bao G., Huo T., Wang Z., He X., Dong G. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci. 2009, 100:1300-1305.
31. Han J., Qureshi A.A., Prescott J., Guo Q., Ye L., Hunter D.J., De Vivo I. A prospective study of telomere length and the risk of skin cancer. J. Invest. Dermatol. 2009, 129:415-421.
32. Mirabello L., Richards E.G., Duong L.M., Yu K., Wang Z., Cawthon R., Berndt S.I., Burdett L., Chowdhury S., Teshome K., Douglass C., Savage S.A. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int. J. Mol. Epidemiol. Genet. 2011, 2:19-29.
33. Risques R.A., Vaughan T.L., Li X., Odze R.D., Blount P.L., Ayub K., Gallaher J.L., Reid B.J., Rabinovitch P.S. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2649-2655.
34. Willeit P., Willeit J., Mayr A., Weger S., Oberhollenzer F., Brandstatter A., Kronenberg F., Kiechl S. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304:69-75.
35. Widmann T.A., Herrmann M., Taha N., Konig J., Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp. Hematol. 2007, 35:939-946.
36. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645.
37. Meeker A.K., Argani P. Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation?. J. Mammary Gland Biol. Neoplasia 2004, 9:285-296.
38. Meeker A.K., Hicks J.L., Iacobuzio-Donahue C.A., Montgomery E.A., Westra W.H., Chan T.Y., Ronnett B.M., De Marzo A.M. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 2004, 10:3317-3326.
39. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat. Res. 1991, 256:271-282.
40. Artandi S.E. Telomere shortening and cell fates in mouse models of neoplasia. Trends Mol. Med. 2002, 8:44-47.
41. Morla M., Busquets X., Pons J., Sauleda J., MacNee W., Agusti A.G. Telomere shortening in smokers with and without COPD. Eur. Respir. J. 2006, 27:525-528.
42. Nettleton J.A., Diez-Roux A., Jenny N.S., Fitzpatrick A.L., Jacobs D.R. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Clin. Nutr. 2008, 88:1405-1412.
43. Svenson U., Nordfjall K., Stegmayr B., Manjer J., Nilsson P., Tavelin B., Henriksson R., Lenner P., Roos G. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res. 2008, 68:3618-3623.
44. Gramatges M.M., Telli M.L., Balise R., Ford J.M. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol. Biomarkers Prev. 2010, 19:605-613.
45. Shen M., Cawthon R., Rothman N., Weinstein S.J., Virtamo J., Hosgood H.D., Hu W., Lim U., Albanes D., Lan Q. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 2011.
46. Liu J., Yang Y., Zhang H., Zhao S., Liu H., Ge N., Yang H., Xing J.L., Chen Z. Longer leukocyte telomere length predicts increased risk of hepatitis b virus-related hepatocellular carcinoma: a case-control analysis. Cancer 2011.
47. Lan Q., Cawthon R., Shen M., Weinstein S.J., Virtamo J., Lim U., Hosgood H.D., Albanes D., Rothman N. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin. Cancer Res. 2009, 15:7429-7433.
48. Svenson U., Ljungberg B., Roos G. Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res. 2009, 69:2896-2901.
49. Benetos A., Okuda K., Lajemi M., Kimura M., Thomas F., Skurnick J., Labat C., Bean K., Aviv A. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001, 37:381-385.
50. Unryn B.M., Cook L.S., Riabowol K.T. Paternal age is positively linked to telomere length of children. Aging Cell 2005, 4:97-101.
51. Jeanclos E., Schork N.J., Kyvik K.O., Kimura M., Skurnick J.H., Aviv A. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 2000, 36:195-200.
52. Mayer S., Bruderlein S., Perner S., Waibel I., Holdenried A., Ciloglu N., Hasel C., Mattfeldt T., Nielsen K.V., Moller P. Sex-specific telomere length profiles and age-dependent erosion dynamics of individual chromosome arms in humans. Cytogenet Genome. Res. 2006, 112:194-201.
53. Lee D.C., Im J.A., Kim J.H., Lee H.R., Shim J.Y. Effect of long-term hormone therapy on telomere length in postmenopausal women. Yonsei Med. J. 2005, 46:471-479.
54. Aviv A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J. Mol. Med. 2002, 80:689-695.
55. Mooi W.J., Peeper D.S. Oncogene-induced cell senescence-halting on the road to cancer. New Engl. J. Med. 2006, 355:1037-1046.
56. Babizhayev M.A., Yegorov Y.E. Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration. Fundam. Clin. Pharmacol. 2010.
57. Hoffmann J., Erben Y., Zeiher A.M., Dimmeler S., Spyridopoulos I. Telomere length-heterogeneity among myeloid cells is a predictor for chronological ageing. Exp. Gerontol. 2009, 44:363-366.
58. Spyridopoulos I., Erben Y., Brummendorf T.H., Haendeler J., Dietz K., Seeger F., Kissel C.K., Martin H., Hoffmann J., Assmus B., Zeiher A.M., Dimmeler S. Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2008, 28:968-974.
59. Zheng Y.L., Ambrosone C., Byrne C., Davis W., Nesline M., McCann S.E. Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res. Treat. 2010, 120:769-775.
60. Barwell J., Pangon L., Georgiou A., Docherty Z., Kesterton I., Ball J., Camplejohn R., Berg J., Aviv A., Gardner J., Kato B.S., Carter N., Paximadas D., Spector T.D., Hodgson S. Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity?. Br. J. Cancer 2007, 97:1696-1700.
61. Kim S., Sandler D.P., Carswell G., De Roo L.A., Parks C.G., Cawthon R., Weinberg C.R., Taylor J.A. Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the sister study. Cancer Causes Control 2011, 22:1061-1066.
62. Mirabello L., Huang W.Y., Wong J.Y., Chatterjee N., Reding D., Crawford E.D., De Vivo I., Hayes R.B., Savage S.A. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009, 8:405-413.
63. Liang G.Y., Qureshi A.A., Guo Q., Vivo I.D., Han J. No association between telomere length in peripheral blood leukocytes and the risk of non-melanoma skin cancer. Cancer Epidemiol. Biomarkers Prev. 2011.
64. Prescott J., McGrath M., Lee I.M., Buring J.E., De Vivo I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer 2010, 116:4275-4282.
65. De Vivo I., Prescott J., Wong J.Y., Kraft P., Hankinson S.E., Hunter D.J. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1152-1156.
66. Lee I.M., Lin J., Castonguay A.J., Barton N.S., Buring J.E., Zee R.Y. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study. Clin. Chem. Lab. Med. 2010, 48:259-262.
67. Zee R.Y., Castonguay A.J., Barton N.S., Buring J.E. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2280-2282.
68. An H.X., Niederacher D., Picard F., van Roeyen C., Bender H.G., Beckmann M.W. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer 1996, 17:14-20.
69. Gorgoulis V.G., Koutroumbi E.N., Kotsinas A., Zacharatos P., Markopoulos C., Giannikos L., Kyriakou V., Voulgaris Z., Gogas I., Kittas C. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. Mol. Med. 1998, 4:807-822.
70. Baudis M. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer 2007, 7:226.
71. Allshire R.C., Dempster M., Hastie N.D. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res. 1989, 17:4611-4627.
72. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30:e47.
73. Unryn B.M., Hao D., Gluck S., Riabowol K.T. Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin. Cancer Res. 2006, 12:6345-6350.
74. Fern L., Pallis M., Ian Carter G., Seedhouse C., Russell N., Byrne J. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS. Br. J. Haematol. 2004, 126:63-71.
75. Prorok P.C., Andriole G.L., Bresalier R.S., Buys S.S., Chia D., Crawford E.D., Fogel R., Gelmann E.P., Gilbert F., Hasson M.A., Hayes R.B., Johnson C.C., Mandel J.S., Oberman A., O'Brien B., Oken M.M., Rafla S., Reding D., Rutt W., Weissfeld J.L., Yokochi L., Gohagan J.K. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin. Trials 2000, 21:273S-309S.
76. Schroder C.P., Wisman G.B., de Jong S., van der Graaf W.T., Ruiters M.H., Mulder N.H., de Leij L.F., van der Zee A.G., de Vries E.G. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br. J. Cancer 2001, 84:1348-1353.
77. Calado R.T., Cooper J.N., Padilla-Nash H.M., Sloand E.M., Wu C.O., Scheinberg P., Ried T., Young N.S. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia 2011.
78. Greider C.W., Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987, 51:887-898.
79. Aviv A., Valdes A.M., Spector T.D. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int. J. Epidemiol. 2006, 35:1424-1429.
80. Leach N.T., Rehder C., Jensen K., Holt S., Jackson-Cook C. Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidy. Mech. Ageing Dev. 2004, 125:563-573.
81. Xing J., Ajani J.A., Chen M., Izzo J., Lin J., Chen Z., Gu J., Wu X. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev. Res. (Phila) 2009, 2:459-465.
82. Zheng Y.L., Loffredo C.A., Shields P.G., Selim S.M. Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis 2009, 30:1380-1386.
83. Matsubara Y., Murata M., Yoshida T., Watanabe K., Saito I., Miyaki K., Omae K., Ikeda Y. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem. Biophys. Res. Commun. 2006, 341:128-131.
84. Savage S.A., Stewart B.J., Eckert A., Kiley M., Liao J.S., Chanock S.J. Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint. Hum. Mutat. 2005, 26:343-350.
85. Savage S.A., Chanock S.J., Lissowska J., Brinton L.A., Richesson D., Peplonska B., Bardin-Mikolajczak A., Zatonski W., Szeszenia-Dabrowska N., Garcia-Closas M. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br. J. Cancer 2007, 97:832-836.